Blunt S B, Sandler L M, Burrin J M, Joplin G F
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
Q J Med. 1990 Nov;77(283):1113-33. doi: 10.1093/qjmed/77.2.1113.
The efficiency of various laboratory and radiological investigations in the differentiation of ectopic from pituitary dependent Cushing's syndrome was studied, based on findings in 23 patients with verified Cushing's disease and seven patients with the ectopic ACTH syndrome. Clinical features strongly favouring the ectopic type were male sex and history for less than 18 months. Basal biochemical features strongly indicating the ectopic syndrome included plasma K+ less than 3.0 mmol/l and HCO3 greater than 30 mmol/l; serum cortisol at 9 a.m. or midnight of greater than 800 nmol/l; urine free cortisol greater than 1300 nmol/24 hours; plasma ACTH greater than 100 ng/l. In the high-dose dexamethasone suppression test, suppression by less than 50 per cent of 9 a.m. serum cortisol, urine free cortisol or 17-oxogenic steroids was usually indicative of an ectopic source of ACTH. A mean suppressed value of greater than 450 nmol/l for the 9 a.m. and midnight cortisol combined occurred in all of those with the ectopic syndrome, but in none of the 23 patients with Cushing's disease. For urine free cortisol, a mean suppressed value of less than 1000 nmol/24 hours was found in all patients with Cushing's disease, but in none of those in the ectopic group. In the metyrapone test, there was an increase of less than or equal to 3-fold in 11-deoxycortisol at 24 hours in patients with ectopic ACTH; the increase was greater than 3-fold in all but one of the patients with Cushing's disease. Failure to respond to either dexamethasone or metyrapone was found in only one of the patients with Cushing's disease (Patient 16); in the ectopic group, all patients except Patient D failed to respond to either test. It is concluded that patients presenting with clinically obvious Cushing's syndrome along with measurable plasma ACTH can be reliably divided by conventional tests into those that are driven from the pituitary and those driven by ectopic ACTH.
基于23例确诊库欣病患者和7例异位促肾上腺皮质激素(ACTH)综合征患者的研究结果,对各种实验室检查和影像学检查在鉴别异位性与垂体依赖性库欣综合征方面的效率进行了研究。强烈提示异位类型的临床特征为男性以及病程少于18个月。强烈提示异位综合征的基础生化特征包括血浆钾离子浓度低于3.0 mmol/L以及碳酸氢根离子浓度高于30 mmol/L;上午9点或午夜血清皮质醇高于800 nmol/L;尿游离皮质醇高于1300 nmol/24小时;血浆ACTH高于100 ng/L。在高剂量地塞米松抑制试验中,上午9点血清皮质醇、尿游离皮质醇或17-氧代类固醇的抑制率低于50%通常提示ACTH的异位来源。所有异位综合征患者上午9点和午夜皮质醇的平均抑制值合并后大于450 nmol/L,但23例库欣病患者均未出现这种情况。对于尿游离皮质醇,所有库欣病患者的平均抑制值低于1000 nmol/24小时,但异位组患者均未出现这种情况。在甲吡酮试验中,异位ACTH患者24小时11-脱氧皮质醇的增加小于或等于3倍;除1例库欣病患者外,所有库欣病患者的增加均大于3倍。仅1例库欣病患者(患者16)对地塞米松或甲吡酮无反应;在异位组中,除患者D外,所有患者对这两种试验均无反应。得出的结论是,临床表现明显的库欣综合征且血浆ACTH可测的患者,通过传统检查可可靠地分为垂体驱动型和异位ACTH驱动型。